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APPROACHING ECONOMIC ISSUES










In the tradition of transferring models and concepts from one science to another, our 
research explores the possibility of importing some concepts, definitions and 
approaches from human epidemiology to economic research, based on the extensive 
usage of medical terms and concepts in economy. The article explores some basic 
epidemiology concepts and their possible relevance to economic research, with the 
final goal to provide a new viewpoint over the economic phenomena, usable in 
economic crisis. 
The article introduces the concept of “business epidemiology” as a possible scientific 
approach to the economic crisis. 
Keywords: epidemiology; business disease; company health; research methodology; 
financial contagion
JEL Classification: E32, E60, F41 
1. Prologue 
Some economists have observed that the economic crisis, as a phenomenon, has 
spread throughout the financial markets, manifesting itself like a “financial disease” 
infecting the stock-exchange, and, from there, the world financial markets and beyond, 
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to the small businesses. This is sometimes described as a case of financial contagion, 
being metaphorically described by Nouriel Roubini as a “pandemic” (Roubini, 2008).
The metaphors “financial disease” and “economic disease” were used, for a long time, 
to describe the economic crisis in countless contexts. As another example, Piia-Noora 
Kauppi, Managing Director of the Federation of Finnish Financial Services uses the 
expression “health of public finances” (Kaupi, 2010). Examples of usage of 
expressions like economic recovery, economic health, financial health, are included in 
scientific papers and in economic literature, as metaphors, in a wide variety of 
contexts. The money and the financial markets are in many cases described as the 
“circulatory system” of the economy by the finance authors. 
In a declared “clinical analysis”, Bertrand Candelon affirms: “The analogy to medicine 
is straightforward in the case of financial crisis, especially if one remembers the name 
given to the recent crises: the Asian flu or the Russian cold” (Candelon, 2008, p. 7). 
Thus, we have to observe the fact that there are medical terms and concepts 
associated with the economic crisis. Even linguistics researchers have noticed this 
trend. In the context of analysis of the economic argumentation, Rigotti and Palmieri 
affirm: “very often, financial/economic crisis as well as political and social crisis, are 
read in terms of illness, of disease, where the patients correspond to the concerned 
contexts in trouble – ranging from the market, to the country, from the industrial sector 
to single firms – and the failure of these organizations is frequently identified with their 
death” (Rigotti and Palmieri, 2010).
Thus, we consider the use of medical terms in economics as a fact, because, in order 
to explain their intuition and empirical observations regarding the crisis, and many 
other dangerous conditions of economies and businesses several scientists, 
politicians, journalists and managers have used these terms, and, as a consequence, 
we consider there is a need for a conceptual investigation using this medical-
economical approach. “The use of sectors/lens has the advantage of highlighting, and, 
therefore, making easier to see certain qualities of whatever is being observed. It is a 
way of unpacking the confusion of the whole” (Buzan, Jones and Little, 1993, p. 31). 
As different authors use a “medical lens” aiming to see the economy in a more clear 
way, we should attempt to study this “lens” and to some extent perfect it. 
The use of medical terms may be seen as simple use of metaphors and analogies, but 
just as well as a need for a better conceptual frame in economics. We do not argue 
against the fact that as they are, those metaphors may not describe exactly the 
phenomenon, because companies are not humans and the human diseases are a 
different matter than business diseases, but, nevertheless they may improve what we 
use now. 
Our goal is to attempt to link the economic-medical metaphoric expressions to 
economic science concepts, and, in this case, to determine some facts that emerge 
from this kind of conceptualization. 
Historically, from time to time, in the economic sciences several concepts and 
approaches have been imported from different sciences, like physics, meteorology, 
mathematics, biology and medicine. Using this perspective, in economics the 
“diagnostic” term and “neural networks” expressions, which came from medicine, are 
already accepted and widely used. Approaching Economic Issues through Epidemiology 
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In our opinion, if a migration of concepts from the medical field is to be scientifically 
sound, the most usable science to be related to “pandemic” diseases of the economy 
is the Epidemiology. This is because Epidemiology is the medical science that deals 
with diseases affecting large numbers of people at a global scale, and with especially 
contagious (communicable) diseases.
Thus, the question is if Epidemiology-Economics migration of concepts could, and 
should help create a better understanding of economic crisis. If this is the case, which 
economic science should be researching this specific approach? 
In a reverse logic, the epidemiology has imported some concepts from economic 
sciences, but from a medical management point of view. Epidemics have been 
studied from an economic point of view by several scholars [(Mullins, 1994), (Bloom 
and Canning, 2006)], and there are two established fields of research, the Economic 
Epidemiology, and the Pharma-economics. The Economic Epidemiology studies the 
economic impact of epidemics, in order to determine an economic manner of dealing 
with an epidemic. The Pharma-economics studies the optimal cost-efficient treatment 
procedures for drug prescription, as field of health management. 
In order to avoid confusions of terms we will use the term “business epidemiology” as 
the epidemiological research of unspecified “business diseases”. The premise of 
“business epidemiology” is that some conditions can be transmitted from a business to 
another and spread in a networked economy, if “financial contagion” can be seen as 
“epidemiological-like” transmissions from business to business and from market to 
market, with the final purpose to identify disorder’s “treatments”. 
2. The disease concept in economics 
In medical terms, a disease is described as an abnormal condition of an organism that 
impairs bodily functions. In Epidemiology, the social, or work-related disease is 
described as a human body disease generated by economic environment. Those 
diseases are poverty-linked disease (malnutrition) and work-related diseases (like 
silicosis for glass workers, led poisoning for workers that use lead, radiation exposure 
for uranium miners, depression generated by unemployment, headache generated by 
stress, and so on). 
In economics, the term “disease” is not defined, but sometimes used in different 
contexts to describe abnormality of economic systems, ranging from company, 
branch, national, regional, even global economy, or a market or a government entity. 
In some cases, disease is associated with bankruptcy (or default) risk. “Disease” is 
both in medicine and in economics the opposite of “health”. 
In order to define properly the economic entities diseases, we should always identify 
the type of entity associated with abnormality. This is because economic phenomenon 
is seen in a different manner at different levels, so a market disease is not the same 
with a SME disease. They may be linked, they may be correlated or not, so we should 
approach them in a different manner. 
In our opinion, most economic phenomenon that manifest at larger levels of the 
economy are generated by behavior regarding, related to, or influencing businesses. Institute of Economic Forecasting
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The basic “business organisms” are the companies and their body comprises the 
combination of resources and processes reunited into the company system. From 
systemic viewpoint, both a human body and a company are seen as systems.
If we use the “medical lens” on companies and use the “disease” concept from 
medicine on them, we see companies that show abnormalities as “diseased”, as long 
as those abnormalities impair their functions. We must emphasize the impairment of 
functions because “abnormal” may be seen as “original” and this is not implicitly a 
dangerous state. 
If we need an expression that may sum the association between economic 
phenomenon and disease, we could use “economic disease”. The functioning of 
companies is generally defined as business activity, so another correct association is 
“business disease”. 
 “Economic disease” or “business disease” should be defined in this perspective as an 
abnormal condition of an economic entity that impairs its normal functions. We can 
use “economic disease” for an abnormality at macro-level and “business disease” for 
an abnormality at micro-level. Probably future evolutions may determine a different 
approach. A “business disease” example is the loss caused by management 
disorders; an “economic disease” example is a structural inefficiency of the economy.
What is the use of such an association of terms? Could the business disease concept 
help in some ways to explain better the economy? In our opinion it does, because it 
may help concentrate in a usable manner information and experience regarding 
complex, repetitive, negative phenomena that damage businesses. Our hypothesis, 
based on medicine experience and translated to economics is that a known disease is 
by far more likely to be cured, as compared to an unknown condition. This means that 
if we manage to identify a known disease and known approaches that may prevent, or 
treat such a condition, and concentrate all this on a disease description, with 
experience and research documented, and procedures to address it, we have a 
usable, easy to replicate solution to economic problems. 
Since there is a wide variety of diseases, the first step in determining the existence of 
the disease is to ascertain if the signs and symptoms of a patient are normal or 
abnormal.
Case definition is important to define for each kind of disease, being the first step in an 
epidemic outbreak fight. In economic terms, the existence of a business disease 
should be defined as a combination of indicators decline (such as, but not limited to, 
turnover, profit and related indicators, assets, liabilities,  number of employees, 
employee’s wages, etc). All those indicators would suggest that a company may have 
a sort of disease or not. This can be done by using scores, Key Performance 
Indicators.
In medical terms, health may be defined as a state of complete good physical, mental 
and social status, comprising the lack of illness and infirmity and a dynamic adaptation 
and equilibrium between the human organism and the surrounding environment. 
In economic and business terms, health may be defined as a state of good of all 
assets, management, workforce, public image and the ability to adapt the company to  Approaching Economic Issues through Epidemiology 
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the changes of the surrounding geographic, climatic, social, economic and political 
environment.
In medical terms, the disease is a consequence of the failure of the human body to 
adapt to biological, physical, chemical or social aggressions. 
In business terms, the disease may be the consequence of the failure of a company to 
adapt to economic, social, environmental or political aggressions. 
3. The Financial Contagion 
There is a documented, researched business disease, known in Finance as “financial 
contagion”, and there are already implemented procedures designed to prevent, 
contain and treat the financial contagion. 
The contagion phenomenon is quite known to researchers, especially in Finances. 
The “financial contagion” and “financial contagion risk” concepts have been in use for 
quite some time related to the interbank market impact of a bank default. Researching 
financial contagion, Dirk Schoenmaker has proven, using data regarding bank failures 
in USA between 1880 and 1934, that “bank failures are dependent after controlling for 
macro-economic influences” (Schoenmaker, 1996). Investigating the contagion in the 
emerging markets, specifically Latin American countries, Rodrigo Valdez has 
discovered that “probability of repayment of a country is negatively affected by 
illiquidity of other countries” (Valdez, 1997). 
We have identified studies made in Finland, Belgium, the United Kingdom, Germany, 
and Romania related to this topic, most of them focusing on the case of a sudden 
default of a major bank and the possible contagion to other banks, with various 
models used for this purpose. 
Table 1
Data used for financial contagion research 
Study Objectives  Data  used 
(Dardac and 
Moinescu, 2006) 
Bank default contagion risk caused by 
fraud
Interbank exposures matrix 
Systemic risk level 
Systemic risk severity 
(Iyer and Peydró, 
2006)
Financial contagion occurrence, case 
study in India, State of Gujarat 
Interbank exposures, financial 
statements, press releases 
(Van Lelyveld and 
Liedorp, 2006) 
Contagion models, Netherlands data 
case study 
Interbank lending matrix 
Survey 
Researchers involved in this matter are usually familiar with banking industry, and 
more specific to the National Banks, so the reasons of their interest to direct interbank 
contagion are obvious. 
Most banks should use risk management tools, as provided by Basel I and Basel II 
Agreements, designed, among other things, to diminish default contagion through the 
banking system. The national banks and governments are usually very sensitive to 
bank difficulties and tend to intervene rapidly in order to isolate and contain the case. 
The present situations suggest that systemic banking problems may “infect” 
governments as well (the 2010 Ireland  case). Institute of Economic Forecasting
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In our opinion, this system is, to some extent, flawed, as banks rarely go bankrupt 
accidentally, for internal causes only. Because banks are players of an oligopoly 
market, usually their behavior is likely to be copied by other banks, as long as profits 
are apparent. So the issue here is not the contagion of the “default’, but the contagion 
of the behavior leading to default, and that spreads some time before the actual 
“death by bankruptcy”. Another known issue, rarely taken into account, is that the 
financial contagion seen as banks’ default generating other banks’ defaults, may not 
be triggered by the banks themselves, but by banks’ customers (creditors or debtors), 
and exposure alone may not be relevant. When market panic sets in, all usual 
premises become irrelevant, and the logic of panic behavior becomes the rule, with 
new premises. If a bank becomes bankrupt, it may trigger other banks to fail directly 
because of exposures, but that is not the main risk. The main risk is the “contagion” of 
financial market panic behavior.
We consider the interbank financial contagion as it was studied a fairly rare 
occurrence, but very spectacular. Bank failures are rare as compared to smaller size 
business failures.  In a metaphoric way, bank failures are like air crashes, small 
business failures are like car crashes. There are thousands of business failures for 
one bank crash, so we have to assume that interbank financial contagion is just one of 
many diseases. 
At World Bank level, the financial contagion is defined using three levels, a broad 
definition, a restrictive definition and a very restrictive definition. 
The broad definition states: “Contagion is the cross-country transmission of shocks or 
the general cross-country spillover effects” (The World Bank, 2010).  This is a 
macroeconomic level of the contagion, and international financial markets behavior is 
the focus of the definition. This also implies that contagion is an international 
phenomenon. We do not interpret contagion as a strictly international matter, as 
financial market shocks first appear and spread on a specific regional or national 
market.  
The restrictive definition states: “Contagion is the transmission of shocks to other 
countries or the cross-country correlation, beyond any fundamental link among the 
countries and beyond common shocks. This definition is usually referred as excess 
co-movement, commonly explained by herding behavior” (The World Bank, 2010). 
Monica Billio and Massimiliano Caporin characterized this definition as the most 
controversial definition (Billio and Caporin, 2010), and for good reason. Shocks are 
visible and spectacular phenomena, but they are just a small part of the possible 
transmissions of factors that may trigger a crisis situation. Beyond that, shocks are 
short-term explosive events, but they may be the visible part of an underlying 
condition of economies that spread a long time before.
The very restrictive definition states: “Contagion occurs when cross-country 
correlations increase during ‘crisis times’ relative to correlations during ‘tranquil times’” 
(The World Bank, 2010). This is also a debatable definition, because contagion most 
likely occurs during tranquil times and becomes visible during crisis times.
Another definition of contagion may be “the migration of market disturbances  - mostly 
those having a negative impact on the market – from one country to another” 
(Ionescu, Vilag, Vasile and Toader, 2009). Approaching Economic Issues through Epidemiology 
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“The default of an agent can generate a diffusion of bankruptcies across the network 
and the likelihood of this phenomenon depends on the structure of the network” 
(Gallegati, Delli Gati, Greenwald, and Stiglitz, 2008). This diffusion is actually a 
contagion, and the level of the diffusion studied is related to company level. 
We do not intend to discuss either the World Bank definition or other definitions 
focused on international financial markets or international trade, as their definitions 
suit very well their purpose, and macroeconomic impact level; instead, we intend to 
focus on a much detailed level of contagion, as we consider companies the most 
important subject of contagion. Our definition of contagion, based on epidemiological 
approach is: a direct or indirect transmission of a business disease from a company to 
another. According to wider approaches, the definition we propose for contagion is: a 
direct or indirect transmission of a market, economy, and branch disease. 
Thus, from our point of view, the “financial disease” is a transmission of financial 
disorders from a company to another. From this point of view, the interbank financial 
contagion is the transmission of financial disorders from a bank to another. 
Contagion phenomenon does not limit to financial markets. In a networked economy, 
clusters of companies work together and generate a synergic mutual benefit. 
However, as a study made by Wu Bao, Chi Renyong and Shen Yan Zhejiang has 
shown: “inter-firm network would derive unexpected risks for clustered firm, and cause 
risk agglomeration in industrial cluster by diffusing and superimposing risk impact from 
individual firm” (Wu, Chi, and Shen, 2010). This risk accumulation is derived from 
inter-firm complex exposures, and is consistent with a different type of contagion, 
much more complex than the financial contagion. 
“Financial crises often follow what appear to be bubbles in asset prices” (Franklin and 
Gale, 1998). In our interpretation, this means the crisis symptom follows other 
symptoms of a business disease. And the financial contagion aspect is just a 
dimension of a wider “economic health” issue. 
In an epidemiological approach to business, we should have data regarding 
symptoms, risk factors, which should enable us to identify the presence and contagion 
of a business disease, especially known, or, even unknown, and a system in place 
that should monitor, investigate and deal with possible outbreaks before contagion 
becomes critical, and a widespread economic crisis sets in. 
The main point and major significance of the financial contagion phenomenon is that 
this is a business disease, and that it spreads from business to business. Our concern 
is that there are other less obvious business diseases which are not as well 
documented, but may generate just as much loss to the economy. 
However, as a “contagious business disease” by our approach, the “case definition” of 
a bank default should be a little different. Banks may be less exposed to contagion, as 
compared to other businesses, as they benefit from a wide range of systems designed 
to block the spread of such “disease”.Institute of Economic Forecasting
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4. Methods for identifying contagion 
The studies we have mentioned before investigated several mathematical models 
usable as a base for future contagion studies. However, what has to be emphasized is 
the required data for such models, based on known interbank market exposures (for 
interbank contagion), or based on stock market data. 
Exposures of the banks may be known in some countries, but there is no such 
available data regarding a wider array of companies. We do not know of any mean to 
determine all relations between all companies at national and international level, and 
their financial behavior. Thus, those models may be usable for “financial contagion” of 
the interbank lending market, but they lack the data required to determine financial 
contagion risk and possible ripple effects in other branches or at national economy 
levels. Therefore, the financial contagion is most likely to happen in all sorts of 
companies, so some system of research is obviously required. 
In an ideal data accessibility heaven, type of Leontief
4 model could be used to create 
a representation of reletionships beween all companies, as an basis for known events 
ripple effects empiric determination.
In such a case, the general exposure matrix would be defined as a matrix containing 
all exposures of all companies to all companies. In reality, considering the size of such 
a matrix, the required data needed and the time required to collect, verify and process, 
this approach it is not likely to be feasible, even if today’s computing and data transfer 
technology could suggest it may be technically possible. Another weak point of this 
study is that exposure is defined as receivables on long term or short term. 
Receivables do not show the whole picture, as size of the relationship between 
entities. Losing receivables may be less an issue as compared to losing turnover, 
especially if we consider upstream-downstream relationships. Thus, in order to use a 
systemic view and map the input-output relationships, we should use at least these 
two dimensions of exposures, but we can be sure that further research may identify 
other significant measurable direct relationships. 
In a research over international trade contagion, Raja Kali and Javier Reyes use a 
network study approach (Kali and Reyes, 2010). They measured the connectedness 
of markets using some indicators specific to networks like node degree centrality, 
importance of country, maximum flow, using data from NBER-UN word trade 
database. Again, this is an approach highly interesting as a methodological 
inspiration, but unusable at this time for more detailed national, branch, regional 
networks, as data required is quasi-unavailable.
However, following this path, instead of a matrix, we can imagine a network, where 
each company is a node and relationships are the channels of contagion. In order to 
be functional, a model based on this framework would need a map of relationships, 
and this is a huge undertaking by itself. Since each company has different sensitivity 
to contagion, the model would imply the existence of some data regarding the 
company, allowing to measure or predict to some extent the reaction to contagions. 
                                                          
4 We refer to an input-output analysis similar as a concept to the one used by W. Leontief, but 
using companies, not branches, and inputs and outputs seen as financial flows between them.  Approaching Economic Issues through Epidemiology 
Romanian Journal of Economic Forecasting – 1/2011  265
The data available should allow a determination of node degree, centrality, importance 
of company, maximum flow. 
All this macro-models seem usable, but they have the same major flaw, they are 
based on old data, as time is needed to collect all the data, so they most likely would 
not be able to generate warnings early enough in most situations. Monitoring the 
required data for such macro-models, either based on a Leontieff table or network 
focused models is less likely to be feasible at micro-level. As XBRL itself and its use 
expand, and accounting evolves, such a system being put in place in a foreseeable 
future is not unthinkable. This would mean having real time financial and trade 
statements of some sort available online for whole economies, and maybe a stock 
market based on real-time fundamental data, instead of a market based on 
speculation over other player’s response.
Thus, if systematic, large scale model-based research is less likely to be feasible, we 
are suggesting a change of perspective. Instead of researching huge networks we 
suggest to study negative phenomenon starting from the most basic subsystem, the 
company, and gathering information based on repetitive negative phenomenon, such 
as financial contagion. 
What we propose is to see companies like living creatures, parts of an economic 
ecosystem (national or global market). This is by itself not a new approach, as there 
are many scholars that have seen businesses and economic structures as “living 
organisms”, capable of self-sustainability and self-replication. Some of them 
introduced also the biological concept of autopoiesis in the study of economic systems 
[(Zeleny, 1997), (Boulding, 1980), (Teubner and Alberto, 1992)]. Milan Zelezny has 
characterized economic systems as being either self-sustaining (autopoietic), either 
sustained by other sustainable systems (heteropoietic), or resource depleting systems 
(alopoietic).  In this view, a company can be defined as sustainable, thus healthy if it is 
alopoietic or heteropoietic in an autopoietic economy (macro-system). Thus, if we go 
further, we can define business disease as a condition of an entity that may generate 
the transformation of the economic macro-system from the autopoietic condition to an 
alopoietic condition. A contagion should be the transmission of such a business 
disease. Such contagions are cases of unsustainable assets valuation growth (assets 
ranging from tulip roots, stocks, land, derivates and any other kind of asset), 
generated by a contagion of over-valuation practice, or unsustainable consumption 
growth of non-regenerative resources (oil crisis). 
Companies are constantly changing, evolving, and adapting to their environment, and 
interconnect between themselves. So, instead of attempting to identify all 
relationships, and all characteristics, we propose to focus the research on 
abnormalities, seen as business diseases. This view goes not from macro to micro-
phenomenon but from micro to macro. Thus, instead of attempting to deal with 
contagion from top to bottom, we propose an approach that creates the means to 
research, accumulate information, and later have the means to identify and micro-
manage contagion phenomenon. In order to define contagion, we should identify 
alopoetic behaviors, especially contagious behaviors that generate an alopoetic 
macro-system.  Institute of Economic Forecasting
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An “epidemiological” approach could be feasible, using standard procedures as 
means of identifying the pattern of a business disease (comprising the abnormality 
description, symptoms, the transmission channels, and the risk factors). Such studies 
could be used to issue general recommendations, cases signaling procedures, and 
intervention means, designed to contain the outbreak and reduce the contagion risk, 
and maybe save some of the diseased businesses. This is already done, to some 
extent, in all insolvency procedures, but insolvency reports are not standardized, as 
they are done (in Romania) mostly by lawyers focused on legal procedures rather 
than economics, and once issued, are not centralized and studied systematically in 
search of similarities. Moreover, the relationships with other insolvency cases are not 
mapped in any way. Because of this, at this time, we are lacking data that would 
enable us to determine clearly the existence of a business disease, and identify early 
symptoms. We may know to some extent huge financial contagions, like economic 
crisis at branch, national, regional, or global levels, but smaller contagions are rarely 
observed. If we accept as a fact the financial contagion, and accumulate data 
regarding it, new occurrences could be stopped by monitoring known risk factors, and 
treating smaller grade occurrences before they spread, thus diminishing the economic 
macro-spillovers.
In order to be able to identify systematically the contagious business disease, each 
insolvency case should generate data required for such analysis, including trade, 
credit and taxation figures, and a map of business relationships. The next step should 
be an attempt to link the insolvency cases by means of the direct trade relationships, 
and common trade relationships, and if such links are identified, they should be 
studied separately. This is an investigation similar to an epidemiologic investigation of 
transmittable diseases to humans, and in our view, it makes more sense than 
attempting huge scale data mining, on companies financial data, with debatable 
results. The statistical large scale study stage should be done later, in the research 
phase, when symptoms are clearly determined and risk factors for different business 
disease contagion clearly identified, with the purpose of verification. 
If done properly, in time, we expect this process to have a huge impact on statistical 
surveys objectives, financial reporting, accounting standards, and auditing standards, 
as dangerous conditions should be identified, measured and reported to the creditors, 
investors, monitoring bodies of the financial markets, government and general public. 
As new disease will be identified, and data required for some sort of early warning 
system will be identified, this data will be included in reporting, as significant for the 
business future of the company. This is consistent as a process with the continuous 
evolution of the accounting and auditing standards. However, accounting alone cannot 
give the whole picture of the business disease, as human behavior is the drive of 
company behaviors, but is a good starting point, as much data is available. 
Table 2
Relationship between diagnostic tests and disease 
 Disease 
Indicator results  Present  Absent 
Positive  True positive  False positive 
Negative  False negative  True Negative  Approaching Economic Issues through Epidemiology 
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In terms of disease identification criteria, medicine uses laboratory analysis and 
symptom analysis. Usually, the tests used are interpreted statistically using a 
Gaussian function (normal distribution within a population) based on probability 
distribution. Taking into account the variable degree of precision for each test is 
required. Individually, the test used may indicate positive, negative, but also false 
positive and false negative results One indicator may not point out a disease, but the 
cumulative probability of several indicators points out to a disease, in high probability. 
This may also be the case with companies’ diagnostics indicators. 
In economic terms, if we use a selected group of Key Performance Indicators (KPI) for 
the diagnostic of a company, each can point out the presence or absence of a disease 
with a known probability. Based on known cases, the probability of such significance 
can be determined. However, the indication of the disease is done by the combined 
probability of the whole system of indicators. 
As we have not yet studied a business disease in such a way, the indicators, the 
significance range values and probabilities for the presence of any business diseases 
are yet unknown. And as medical epidemiologic research experience has shown, 
such data are not easily obtained and scientifically validated. However, the approach 
shows promise, as it may help economic researchers to select the KPI systems, 
based on the probability of generating relevant failure risk. Moreover, different 
combinations of KPI may be used to refine the diagnostic of different diseases, after 
diseases have been identified, defined and researched. 
Thus, in our view, researching business disease identification means determining the 
system of indicators that generate the highest accumulated probability to reveal either 
the presence or absence of a company’s dangerous abnormality. This research 
approach could be extended to macroeconomic level, either to study macroeconomic 
entities diseases or, to model the contagion of such business disease in a wider 
context.
This stage of research should rely on insolvency reports for the identification of 
dangerous abnormal conditions, but at later stages could be based on other 
abnormalities reports.
5. Methods of researching a business disease 
As epidemiologic methodology there are three basic types of study: the case study, 
the case control study and the cohort study.
The process of a “business epidemiologic” case study starts with monitoring 
insolvency situations. This can be done using insolvency reports already available as 
data source. Each insolvency report contains a sum of reasons for the insolvency. The 
first grouping should be based on those reasons, as the objective is to identify 
companies with the same insolvency causes.
The next step is based on economic analysis methods, and basic economic 
diagnostic indicators, and mainly contains a determination of past time indicators, and 
identification of correlation between known indicators of the group of “diseased” 
companies. This is the process of identifying the possible source of the business 
disease.Institute of Economic Forecasting
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At this stage, all that can be determined is that there is a group of companies that 
apparently share the same failure reasons, and maybe have some common 
identifiable financial position characteristics and economic behaviors. The next step is 
to determine if there is a link between them, as being the presumed contagion 
channel. A contagion could be assumed if a common link exists, either direct or 
indirect (through an identifiable entity). This is required in order to identify the possible 
transmission means. 
This approach is consistent with the “case series” design used in epidemiologic 
research. However, this type of study cannot be used in order to issue general 
recommendations in epidemiology, as they serve as epidemiologic hypothesis 
generation for further study. In medical epidemiology, the idea study design is to 
compare periods of time when the same patients are exposed to risk factors with 
periods when they are not exposed. In business epidemiology, the same rule should 
apply, comparing the periods of distress with the periods of health, if any. 
As mathematical models usable, network propagation is consistent with graph theory, 
but seems feasible just for a small propagation study. 
A simple approach, based on scoring methods is to weight some indicators in order to 
obtain a custom score for survivability prognosis, or use the Altman Z-Score, or 
Harrod-Domar model of scoring in order to identify some degree of abnormality. As an 
example, the presence of a business disease could be indicated by an unexpected 
failure of a company otherwise expected to be financially stable. As another example, 
the failure of an AAA rated company should show either a serious hidden underlying 
condition, or a contagion. Confirmed predictable failures usually mean known bad 
management and governance issues. They are unlikely to generate a serious 
contagion as banks usually have systems in place that should identify common risk 
factors and procedures in place designed to contain such cases. A higher than usual 
count of failures may be significant and may be a sign of a macro-systemic business 
disease, probably with a longer set-in timeframe.
The most significant cases are the ones when failure was unpredictable using usual 
methods. They show a possible new abnormality. In abnormal conditions, scores 
cannot be used as they are, but their methodology of determination can be used to 
emphasize a certain shift of risk, by using a more complex model. 
The next phase in determining the existence and research of an epidemic business 
disease is the “case control study”. In this phase, subjects exposed to different risk 
factors are compared with subjects who are not exposed. As an example, in economy, 
we can compare companies having similar size, activity, and other characteristics 
from an area with others from other areas (in order to identify some regional factors), 
companies having similar size and location but different branches (in order to identify 
branch-related factors), companies with similar location and branch but different size 
(for size-related factors) and so on. This way the risk factors significance can be 
statistically determined for each disease.
If an abnormal condition is supposed to be present, scoring of any kind is useless 
because the weight of indicators and intervals of score are determined using data 
collected in normal conditions. Even if we had scores determined for abnormal 
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intervals of times between occurrences, it is unlikely that the accounting data they 
should be built upon would be consistent with present-day accounting standards. 
Accounting may not change very much over short periods, but for long periods 
changes are to be expected. So, a different method than scoring is required. In a 
supposed abnormal condition, the vectors representing the diseased companies 
should be compared with other vectors from the control group, containing companies 
that have no exposure to each risk factor. 
The control group should come from the same population of companies and have a 
similar distribution with the diseased group. The most important part of generating a 
valid outcome is a correct selection of the control group companies.
The next step is constructing a simple 2X2 matrix (see Table 3). 
The A/C ratio is expressing the odds of risk factor being present in a disease, while 
the B/D ratio represents the odds of being exposed and not getting the disease. The 
indicator used in epidemiology to express this is the Odd Ratio (OR), being the ratio of 
A/C to B/D. If OR is less than 1 the factor is a protective factor, if OR is close to 1 the 
association is unlikely, if OR is significantly larger than 1 the risk factor is likely to 
cause the business failure. In all cases, some statistical confidence tests are required. 
Table 3
Odd Ratio Matrix 
Risk Factor  Diseased group  Control group 
Exposed A  B 
Unexposed C D 
As a theoretical example, a group of 100 companies in process of insolvency is 
identified, having different size branches and locations.  In order to test the risk 
factors, we choose a control group of 100 companies that have a better financial 
position, but the same branches and locations. 
Table 4
Bank X OR matrix 
Bank X Creditor  Disease present  Disease absent  Total 
Exposed  49 (25%)  70 (35%)  119 (60%) 
Unexposed  51 (26%)  30 (15%)  81 (41%) 
Total  100 (50%)  100 (50%)  200 (100%) 
OR= (49:51):(70:30)= 0.96:2.33=0.4118 
A statistical significance test is required, so we determined by means of the Chi-
square test that the two-sided P value is 0.0040, considered very significant, and that 
the row/column association is statistically significant (confidence interval: 0.2305 to 
0.7357, confidence 95%, using the approximation of Woolf). 
In this case, as values of the Odds Ratio are below 1, the bank X is apparently a 
protective factor. Institute of Economic Forecasting
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Table 5
Client type Y OR matrix 
Customer type Y  Disease present  Disease absent  Total 
Exposed  35 (18%)  2 (1%)  37 (19%) 
Unexposed  65 (33%)  98 (49%)  163 (82%) 
Total  100 (50%)  100 (50%)  200 (100%) 
OR= (35/65):(2/98) = 0.53:0.020=2.65385 
Using Fisher's Exact Test, we determined that the two-sided P value is < 0.0001, 
considered extremely significant, and that the row/column association is statistically 
significant (confidence interval 6.131 to 113.54, confidence 95%, using the 
approximation of Woolf). 
In this case, as OR is above 1; the client Y is likely to be a significant risk factor, and 
should be researched further.  This is because even if most of the diseased group 
was not exposed, a much higher proportion of the control group remained healthy by 
not being exposed. As it is, probably the research should follow the branch of the 
customer Y, the region of the customer, the owner of the customer, in order to identify 
the cause of this, if any. As we can observe for this approach, this is not a 
straightforward approach, as disease in humans as well as disease in companies is 
not generated by a single factor, and sorting the risk factors can be misleading and 
debatable, but is nevertheless a necessary process. 
In both cases, we have used epidemiological statistical freeware software that does 
the calculations and significance tests, and calculate the confidence intervals and P 
values.
As a method, this type of study is not very accurate, but can provide relatively easy 
some useful information regarding the risk factors involved. If the control group is not 
correctly chosen, results may be faulty. As a concept, the “case control” method is 
consistent with the benchmarking type of economic analysis, and the use of Odd Ratio 
is consistent with the survey methodology used commonly in social sciences. 
Apparently, there is nothing new in using epidemiological approach, except the way 
we interpret the data, and the way we suggest it should be concentrated on the 
information obtained. We should point out that in this type of research there are 
inherent difficulties regarding the data availability, especially from the companies that 
are not in difficulty. Companies may be reluctant or refuse to provide such data as 
exposures, bank relations and such, especially in turbulent times. In both cases, we 
have selected exposure for the example, but we have not defined the exposure 
measurement indicator, because the most significant indicator is yet to be determined, 
but it can be either receivables at the end of the year or yearly sales for customer 
type, and credits received for the bank X example. We do not limit the use of the 
method to financial exposures, as all types of exposures could be tested (such as, but 
not limited to: behavior types, branch, location, employee types, and employee 
behaviors).
A more powerful research tool is the epidemiologic cohort study. Such a study is 
based on selecting and monitoring subjects based on initial exposure status. As an  Approaching Economic Issues through Epidemiology 
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example, a study over customer type Y (following the example we have used before), 
considered as a risk factor, should use subjects that are initially non-exposed. The 
research subjects should be separated into two cohorts, one of them being subject to 
exposure, and one functioning as a non-exposed control group. The study will 
investigate the appearance of the disease under research in both cohorts. The 
measuring tool is the Relative Risk (RR) being the measure of difference between 
incidence appearance probabilities in the two cohorts. Based on probabilistic 
calculation, the relative risk indicates better the influence of the exposure. We say that 
X effect is RR times more frequent in exposed cohort than in the unexposed one. 
The RR is a much more relevant estimation than OR, but it costs more, and has to be 
done over a wider timeframe. 
All three types of studies are designed to sort the risk factors as accurately as 
possible. They are all derived from the probability study used in social sciences. 
Determining risks in different ways is common to economic science, and probability 
mathematics is also a common approach. What is different in our approach is the 
hypothesis to be tested, and this is that a certain abnormality can be identified as a 
specific business disease, and as a consequence, later on, after determining the risk 
factors, the occurrence probability can be lowered by controlling those risk factors, at 
macro-level, and, at micro-level, to generate awareness of scientifically determined 
risk factors for businesses, and ways to approach them.
The medical epidemiologic approach paradigm, based on the hypothesis that 
diseases occurrence probability is influenced by a combination of risk factors, each 
contributing to it, is very similar to some economics default risk approaches, but 
seems in our opinion more refined, as it approaches different diseases and determine 
risk factors, compared to a single risk, the default (or bankruptcy) risk. 
We can imagine ways to model exposures in large scale models, based on 
correlations determined by surveys based on public data contained in financial 
statements, but not in such a detailed way as it is required for epidemiologic research. 
This points out that survey is the only method of obtaining data required for such a 
study, and that some kind of exposure measurement should be included in the 
financial statements in order to allow for later stage research over bottom to top 
contagion modeling process at macroeconomic level. Large scale research can only 
be based on available data, so dependent variables are based on financial statement 
derived data, and the independent variable should be the risk factors identified. 
Financial data are standardized, but the risk factors are unlikely to be. This means the 
risk factors should be obtained by other means. On smaller scale, for small numbers 
of companies this is feasible, however there is a confidence relativity derived from 
generalizing the conclusions. A 1:1000 probability becomes highly probable in 
1.000.000 cases. If we investigate contagion cases, we can assume the occurrence 
can, even if unlikely, trigger a disproportionate size event.Institute of Economic Forecasting
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6. Differences in approaching epidemics from 
medical and/or economic perspectives 
There are differences between normality in medicine and normality in economy that 
we must underline. 
Medicine has names for diseases, Economy has not. Even if this statement seems 
irrelevant, in our view it states that economic science concentrates information 
regarding abnormal failure of companies in a simple, bottom-line way, which has little 
relevance in the end. There is no such thing as a “financial diabetes”, “commercial 
flue”, in order to define known, identifiable and repeatable chains of events, sum of 
reasons, and composition of risks that lead to the failure of a business. Knowing a 
disease means usually knowing to a certain extent what is going to happen, and even 
the approach required in order to diminish the failure probability.
All companies report their health status through the financial reports, people do not. 
So, screening the population of companies should be easier. However, in times of 
crisis companies may get ill and die in large numbers before the next annual report. 
Even if there are some score methods that may show a failure probability (Altman Z-
Score, Harrod-Domar), they provide little to no information about the reasons, and 
even less in terms of solutions. 
The health system is expected to have some treatments or cures for all people’s
diseases. There are discussions whether the government should intervene and cure 
the “disease” of any company. However, a widely spread economic disease, affecting 
large numbers of companies, would usually justify the government intervention. The 
main reason for this is the experience of subjective, political and corruption-based 
public intervention. This is where an epidemiologic approach can be actually useful, in 
providing some objective reasons to select, direct and size the government 
intervention in a free market economy.
If self-medication and self-treatment is normal - but not recommended to people - “self 
medication” and “self treatment” is required from the companies, as they are expected 
to solve their own difficulties without government aid. Nevertheless, knowing that there 
is a disease and an accurate diagnostic is the first step for any kind of treatment both 
to humans and companies. In a free market paradigm, companies are expected to be 
able to survive by themselves. But being highly networked and inter-linked, companies 
may be able to absorb most of the shocks, however, sometimes, there are 
phenomena that propagate and replicate themselves within many, most, or even all 
the nodes of the economic network.  These are rare events, which may occur beyond 
the timeframe of most managers’ practical experience, but they can have devastating 
effects on the whole economic system. 
The weak point of this migration of concepts seems to be the different nature of the 
subjects studied, as, obviously, companies are in many ways different than humans. 
Humans are more similar by nature and size as compared to companies, so there are 
significant issues to be researched relating to the use of frequency of occurrence and 
the resultant Odd Ratio and RR significance and confidence. One huge corporation 
failure may be more dangerous than thousands failures of SMEs.  Approaching Economic Issues through Epidemiology 
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In the financial literature, contagion risk is mostly studied in association with the 
“default” of a bank. Thus, the default condition is basically the first business disease 
supposed to be contagious. Using the “medical lens”, this seems to be like 
considering “death” or “coma” a disease. From this point of view, the financial 
contagion, as it is studied now, looks like a human creating an epidemic after its 
death, and the probability of such an occurrence is obviously low. It is more likely such 
a contagion is spread before the default, while the underlying real cause of the default 
was not obvious. 
Abnormalities that are transmitted through the economic network are contagion 
phenomena, and some multiply as they are replicated within the nodes of the network; 
some fade away as they consume their source or as they are contained by immune 
nodes and impermeable links. This is consistent as approach with different disease 
propagations in humans, but, the reasons why, the nodes sizes, the links that allow 
contagion between companies are different. 
7. Taxonomy issues 
The epidemiology can be defined as the branch of medical science dealing with the 
transmission and control of disease or a branch of medicine which studies the incidence 
and distribution of disease in a population, and uses such information to find the causes, 
modes of transmission, and methods for controlling the disease. The term “epidemio-
logy” can be defined according to ancient Greek as the science that regards the entire 
population (epi – above, demos – people, logos - science). In that respect, there is an 
inherent extension of the medical science of epidemiology to all human populations, 
including human organizations, and an extension to economics is quite adequate.
The new research approach, “business epidemiology”, could deal with the study of 
incidence and distribution of business diseases (as described before) in a population 
of companies and could identify the incidence and the distribution of those diseases. 
In order to organize and unify the contagion and spillover effects information, some 
characteristics of diseases research should be used. We are suggesting that the 
following epidemiology concepts are highly significant in this approach.
The epidemiological approach on economics should use the same taxonomic 
approach regarding the basic concepts: 
The source - defined as the economic phenomenon that could trigger the business 
disease. In this stage of research, we are considering that such sources could be (but 
are not limited to) abnormal behaviors that spread into the economy, or resource 
shortages of some kind. Such behaviors examples are tax evasion, payment terms 
habits, over-evaluation of assets, and under-evaluation of services, resource 
shortages could be related to agriculture variable results. If causality is determined, 
the probability of a “source” to trigger the “disease” should be studied. An entity can 
be seen as infected but not diseased. 
The transmission means – being the path used by the source to spread its negative 
influence to other businesses. Some disorders could be transmitted by commercial 
relations from suppliers to consumers, from investors to entrepreneurs and such, or 
as mimetic behaviors. For example, payment delays from the government can trigger Institute of Economic Forecasting
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delays in payments to a wide array of companies, to employees, and from all those to 
banks; an excessive demand for profits on the financial market can trigger high risk-
high profit behavior; tax fraud wealth accumulation, if unpunished, can trigger mimetic 
tax fraud habits. 
The receptivity – is defined as the responsiveness degree of the company to a certain 
negative economic phenomenon. This is mostly related to exposure to the diseased 
areas of the economy. For example, the percentage of receivables per a potentially 
dangerous customer could generate a higher receptivity. The receptivity should be 
measured by the combination of the existing risk factors. 
The epidemic manifestation - forms of an outbreak in economics, usable to assess the 
size and entities required for the research and response to contagion: 
Sporadic outbreak – defined as a rare occurrence of transmittable business disease. 
This is the case of a company behavior triggering abnormal behavior around it, 
affecting a few suppliers and some of its customers.
Epidemic outbreak – geographically wider spread occurrence of business disease. 
This is a case of an outbreak of abnormal behavior in a certain area, like over-
evaluating land in a city. 
Pandemic outbreak – a wide spread business disease occurrence, with multiple 
outbreaks sources. Examples: over-evaluating land, generalized tax fraud, over-
evaluating shares on a financial market. 
Seasonal outbreak – business disease that occurs in a certain period of the year. For 
example, winter cold generates over-consumption of energy for heat, summer heat 
generates over-consumption of energy for cold, and this may trigger energy-related 
abnormalities.
Natural outbreak – business disease induced by environment, government, NGO’s 
and so on. A severe winter can generate several abnormalities in transports; a 
volcanic eruption can trigger air-transport abnormalities, which may propagate to 
touristic services, and so on.
The use of these concepts can help to focus the research of business diseases and 
the response mechanism required. In order to clarify the type of business diseases 
and to concentrate the information that should accumulate over time, all this should be 
organized and codified using a comprehensive system. This can be linked mainly to 
IFRS extension of XBRL taxonomy (Extensible Business Reporting Language) 
evolution, in order to allow comparable data collection systems. In a later stage, as 
XBRL or similar taxonomies are developed, the same taxonomies should be used to 
determine data required for KPI’s. There are several taxonomies usable to identify 
subjects activity (ISIC, NAICS, NACE, ICB), countries (ISO 3166) areas, currencies 
(ISO 4217), and so on.  As a basic methodology research, as XBRL standard financial 
data are used for dependent variables, subject activity, country, currency and such 
data can be used to provide non-numerical independent variables usable for 
regression, and suitable for automated processing. 
From the risk assessment point of view, the development of business related 
taxonomies opens the way for more and more sophisticated models for contagion 
research, as data from different countries becomes comparable. Approaching Economic Issues through Epidemiology 
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Conclusions
As contagion of the financial crisis is a fact, there is an obvious demand for a 
framework designed to deal with it. The research of contagion in banking and financial 
markets has opened an interesting and promising field of research in this direction. 
However, as contagion cannot be limited to banks, there is a clear and unavoidable 
evolution towards a generalized research on contagion. As contagion in human 
society has been studied already for health-related issues by epidemiology, it seems 
logical to us to use that knowledge in other research fields. As our investigation has 
shown, up to a point there are similarities that may be used and concepts that may 
explain the economic phenomenon contagion, but most importantly there are methods 
of research that can be adapted to economics. 
It appears that the new concept of “business epidemiology” provides an original 
framework for economic analysis, which may generate a wide range of research 
topics and may be a solution to organize the government response to contagion, even 
in a free market economy. In a similar way to the response of governments and World 
Health Organization to human epidemics and pandemics, a global economic crisis 
may be approached in a coordinated manner by the proper governmental and global 
organizations.
The business epidemiology may allow integration of several research topics, such as 
systemic approaches, crisis management, public management in well defined and 
usable framework, similar with the one existent in the medical epidemiology field. 
The methodology of epidemiology is pragmatically founded and already verified and 
certified by reality. As epidemiology is the science that is specialized in the research of 
contagion in human society, the methodology used is based on medical sciences but 
also on social sciences and statistics. 
There are already well known and documented procedures, types of studies and 
researches, as well as international treaties that may be used as a base for the 
development of the business epidemiology field. 
While data required for regression type of research based on exposures is quasi-
unavailable, the challenge of the business epidemiologic approach will be to identify 
patterns of available indicators that can be used to identify the presence of absence of 
business diseases, and model the contagion that may be triggered.
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